Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 5/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.47 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.47 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.45 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15430812 | 0.90 | ALDH1A1 (0.64) | FGFR1ALDH1A1TDP1HPGD | |
| SCHEMBL23729173 | 0.79 | HTT (0.54) | FGFR1ALDH1A1HTTHPGDMAPK1 | |
| SCHEMBL19911376 | 0.79 | FGFR1 (1.00) | FGFR1ALDH1A1HTTHPGDMAPK1 | |
| SCHEMBL16919823 | 0.78 | ALDH1A1 (0.58) | FGFR1ALDH1A1HPGD | |
| SCHEMBL23729737 | 0.78 | HTT (0.56) | FGFR1ALDH1A1HTTHPGDMAPK1 | |
| SCHEMBL15430940 | 0.78 | ALDH1A1 (0.48) | FGFR1ALDH1A1TDP1HTTHPGD | |
| SCHEMBL15596380 | 0.77 | ALDH1A1 (0.50) | FGFR1ALDH1A1TDP1MAPK1 | |
| SCHEMBL15430958 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TDP1HTT | |
| SCHEMBL16291053 | 0.76 | HTT (0.62) | FGFR1ALDH1A1HTTHPGDMAPK1 | |
| SCHEMBL18910380 | 0.75 | FGFR1 (0.50) | FGFR1ALDH1A1HTTHPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10236451-B2 | Compound and organic electroluminescent device comprising the same | DOOSAN CORPORATION (KR) | 2019-03-19 | — | — | US | disclosed |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | DOOSAN CORPORATION (KR) | 2015-06-18 | — | — | US | disclosed |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | DOOSAN CORPORATION (KR) | 2015-06-18 | — | — | US | disclosed |
| WO-2014010810-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | 주식회사 두산 (KR) | 2014-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10236451-B2 | Compound and organic electroluminescent device comprising the same | VDAC1, PIEZO1, SLCO4C1 | FGFR1 4472/4885ALDH1A1 566/4885TDP1 3251/4885 |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | VDAC1, ALDH2, VDAC2 | FGFR1 4007/4885ALDH1A1 472/4885TDP1 3260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.